Red cell aplasia due to parvovirus b19 in a patient treated with alemtuzumab
Open Access
- 2 October 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 119 (1) , 279-380
- https://doi.org/10.1046/j.1365-2141.2002.37668.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1HBlood, 2001
- CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.Journal of Clinical Oncology, 1998
- Parvovirus B19 for the hematologistAmerican Journal of Hematology, 1992
- Chronic Bone Marrow Failure Due to Persistent B19 Parvovirus InfectionNew England Journal of Medicine, 1987